These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37659714)

  • 21. Elevated tumor necrosis factor-alpha receptor subtype 1 and the association with abnormal brain function in treatment-resistant depression.
    Huang MH; Chen MH; Tu PC; Bai YM; Su TP; Yang BH; Liu RS; Li CT
    J Affect Disord; 2018 Aug; 235():250-256. PubMed ID: 29660639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic burden of treatment-resistant depression in privately insured US patients with co-occurring anxiety disorder and/or substance use disorder.
    Zhdanava M; Kuvadia H; Joshi K; Daly E; Pilon D; Rossi C; Morrison L; Lefebvre P; Nelson C
    Curr Med Res Opin; 2021 Jan; 37(1):123-133. PubMed ID: 33124940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct patterns of functional brain network integration between treatment-resistant depression and non treatment-resistant depression: A resting-state functional magnetic resonance imaging study.
    Sun J; Ma Y; Guo C; Du Z; Chen L; Wang Z; Li X; Xu K; Luo Y; Hong Y; Yu X; Xiao X; Fang J; Lu J
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jan; 120():110621. PubMed ID: 36031163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic burden of treatment-resistant depression among veterans in the United States.
    Szukis H; Joshi K; Huang A; Amos TB; Wang L; Benson CJ
    Curr Med Res Opin; 2021 Aug; 37(8):1393-1401. PubMed ID: 33879005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.
    Pilon D; Joshi K; Sheehan JJ; Zichlin ML; Zuckerman P; Lefebvre P; Greenberg PE
    PLoS One; 2019; 14(10):e0223255. PubMed ID: 31600244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolomics-based discrimination of patients with remitted depression from healthy controls using
    Hung CI; Lin G; Chiang MH; Chiu CY
    Sci Rep; 2021 Aug; 11(1):15608. PubMed ID: 34341439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Sex-Specific Plasma Biomarkers Using Metabolomics for Major Depressive Disorder in Children and Adolescents.
    Jiang Y; Qin M; Teng T; Li X; Yu Y; Wang J; Wu H; He Y; Zhou X; Xie P
    Front Psychiatry; 2022; 13():929207. PubMed ID: 35911235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and Impact of Treatment-Resistant Depression in Latin America: a Prospective, Observational Study.
    Soares B; Kanevsky G; Teng CT; Pérez-Esparza R; Bonetto GG; Lacerda ALT; Uribe ES; Cordoba R; Lupo C; Samora AM; Cabrera P
    Psychiatr Q; 2021 Dec; 92(4):1797-1815. PubMed ID: 34463905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the Relationship Between Depression Symptom Severity and Health Care Costs for Patients With Treatment-Resistant Depression.
    Lynch FL; Dickerson JF; O'Keeffe-Rosetti M; Chow W; Pesa J
    J Clin Psychiatry; 2022 Feb; 83(2):. PubMed ID: 35120286
    [No Abstract]   [Full Text] [Related]  

  • 30. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
    Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
    J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment patterns in patients with treatment-resistant depression in Danish patients with major depressive disorder.
    Gronemann FH; Petersen J; Alulis S; Jensen KJ; Riise J; Ankarfeldt MZ; Solem EJ; Bødker N; Osler M
    J Affect Disord; 2021 May; 287():204-213. PubMed ID: 33799039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression: A Matched-Cohort Study Using a US Commercial Claims Database.
    Amos TB; Tandon N; Lefebvre P; Pilon D; Kamstra RL; Pivneva I; Greenberg PE
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29474009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population.
    Li G; Fife D; Wang G; Sheehan JJ; Bodén R; Brandt L; Brenner P; Reutfors J; DiBernardo A
    Ann Gen Psychiatry; 2019; 18():23. PubMed ID: 31583010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Putative role of glial cells in treatment resistance depression: An updated critical literation review and evaluation of single-nuclei transcriptomics data.
    Sanadgol N; Miraki Feriz A; Lisboa SF; Joca SRL
    Life Sci; 2023 Oct; 331():122025. PubMed ID: 37574044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suicide-specific mortality among patients with treatment-resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone.
    Kern DM; Canuso CM; Daly E; Johnson JC; Fu DJ; Doherty T; Blauer-Peterson C; Cepeda MS
    Brain Behav; 2023 Aug; 13(8):e3171. PubMed ID: 37475597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.
    Zhang C; Li Z; Wu Z; Chen J; Wang Z; Peng D; Hong W; Yuan C; Wang Z; Yu S; Xu Y; Xu L; Xiao Z; Fang Y
    Psychopharmacology (Berl); 2014 Feb; 231(4):685-93. PubMed ID: 24114429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using an Interpretable Amino Acid-Based Machine Learning Method to Enhance the Diagnosis of Major Depressive Disorder.
    Ho CSH; Tan TWK; Khoe HCH; Chan YL; Tay GWN; Tang TB
    J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592058
    [No Abstract]   [Full Text] [Related]  

  • 38. Economic impact of treatment-resistant depression: A retrospective observational study.
    Pérez-Sola V; Roca M; Alonso J; Gabilondo A; Hernando T; Sicras-Mainar A; Sicras-Navarro A; Herrera B; Vieta E
    J Affect Disord; 2021 Dec; 295():578-586. PubMed ID: 34509073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of home health and other healthcare delivery pathways among privately insured patients with and without treatment-resistant depression.
    Pilon D; Szukis H; Singer D; Morrison L; Sheehan JJ; Lefebvre P
    Curr Med Res Opin; 2020 May; 36(5):865-874. PubMed ID: 31985319
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum Cortisol, Nesfatin-1, and IL-1β: Potential Diagnostic Biomarkers in Elderly Patients with Treatment-Resistant Depression.
    Wu X; Dai B; Yan F; Chen Y; Xu Y; Xia Q; Zhang X
    Clin Interv Aging; 2022; 17():567-576. PubMed ID: 35480963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.